3D Hücre-Protein Etkileşimi Profiling için Mekansal İstatistik ve Açıklanabilir Derin Öğrenme
Spatial Statistics and Explainable Deep Learning for3D Cell-Protein Interaction Profiling
DOI: 10.21203/rs.3.rs-10097353/v1
Spatial Statistics and Explainable Deep Learning for3D Cell-Protein Interaction Profiling
DOI: 10.21203/rs.3.rs-10097353/v1
Linear Gaussian Kernel Cycle Generative Adversarial Networks based Transformer Learning for Early-Stage Stroke Prediction with Parkinson and Skin Disease
DOI: 10.21203/rs.3.rs-9364158/v1
Bidirectional disruption of Lrrk2 function drives T cell dysregulation and an exhaustion-like immune response
DOI: 10.64898/2026.08.16.745139
A multimodal analysis suggests partial IRF8/TLR7-associated myeloid transcriptional convergence between diabetic kidney disease and Parkinson's disease.
DOI: 10.1371/journal.pone.0356691PMID: 42623410
Layered classification in Parkinson's disease: a content analysis of clinical, prodromal, and biological criteria evolution.
DOI: 10.3389/fnagi.2026.1935021PMID: 42694362
From metabolism to neurodegeneration: how microglial functional reprogramming drives neurodegenerative diseases.
DOI: 10.3389/fnmol.2026.1921079PMID: 42694478
TREM2 as a central hub of neuroimmune-metabolic crosstalk in central nervous system disorders: from microglial biology to therapeutic targeting.
DOI: 10.3389/fimmu.2026.1912989PMID: 42694654
Demographic Confounding in Voice-Based Parkinson Disease Screening: Methodological Analysis of the Bridge2AI Voice Dataset.
DOI: 10.2196/95609PMID: 42623305
Regional reduction of high-energy phosphorus metabolites characterizes the cerebellar subtype of multiple system atrophy.
DOI: 10.1038/s41531-026-01537-yPMID: 42624856
Mitochondrial Complex V Dysfunction in Neurodegeneration: Secondary Bystander or Primary Driver?
DOI: 10.3390/brainsci16080890PMID: 42651198
Activation of the Nrf2-ARE Signaling Pathway Mediates the Neuroprotective Effects of Exercise in a Mouse Model of Chronic Parkinson's Disease.
DOI: 10.3390/ijms27167439PMID: 42653440
Pathogenesis-Driven Drug Repurposing with a Self-Nanoemulsifying Delivery System for Parkinson's Disease.
DOI: 10.3390/ph19081311PMID: 42653806
Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.